Abstract
The discussion about breast cancer screening has changed. Yesterday's question was about efficacy—whether screening, under ideal circumstances, can reduce breast cancer mortality. Today's discussion is about a different question, effectiveness. To what extent is current screening, under usual conditions within the community, reducing mortality from breast cancer? The second question may prove to be as complex as the first.

This publication has 21 references indexed in Scilit: